We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

(HealthDay News) — Weeks after ordering staff back to the office, the US Food and Drug Administration (FDA) is letting some employees work from home again, The Associated Press reported. The move ...

Layoffs across health agencies have eliminated workers who handled Freedom of Information Act requests at the CDC, FDA, and NIH.

Our real-world findings indicate that most patients undergoing multiple lines of therapy experience persistent treatment refractoriness and low response rates,” the researchers wrote.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic MSI-H/dMMR colorectal cancer.

Data suggest that the United States had the second highest number of mesothelioma cases and the second highest number of deaths from mesothelioma in 2021. These data were published in Lung Cancer. For ...

The Trump administration is attempting to slash NIH funding, terminate research grants, and reduce the agency’s workforce.

Artificial intelligence (AI) can accurately suggest appropriate adjuvant treatment for patients with early breast cancer, according to research published in JCO Clinical Cancer Informatics.

Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

Surufatinib did not provide an OS benefit over placebo, but there was a high rate of crossover from the placebo group to the surufatinib group.

A federal judge has stopped the Trump administration from cutting $11 billion in public health funding -- at least for now.